Trial Profile
A phase 0 study of Gallium-68-labeled SH7139 for the treatment of non-Hodgkin's lymphoma
Status:
Recruiting
Phase of Trial:
Phase 0
Latest Information Update: 05 Oct 2015
Price :
$35
*
At a glance
- Drugs SH 7139 (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; First in man; Therapeutic Use
- 05 Oct 2015 According to the SHAL Technologies website, the first cohort of three patients has been dosed in this study.
- 05 Oct 2015 New trial record